Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-05

Clinical Trial Update: Investigating the Optimal Management of Dolutegravir Resistance

View source ↗

Summary

A University of Nairobi-led clinical trial is investigating optimal strategies to manage dolutegravir resistance in HIV-1 infection, with recruitment currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dolutegravir (dolutegravir)

Snippet

Sponsor: University of Nairobi | Conditions: HIV-1-infection | Status: RECRUITING